Everything below concerns hGH fragment. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2025-11-01. Numbers and descriptions here follow the published literature rather than marketing material.
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
AOD9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to a short sequence near the end of the 191-amino-acid hormone, often described as residues 176–191 or a related fragment. Researchers designed it to separate metabolic effects from the growth-promoting actions of full-length growth hormone. Early work in the 1990s explored it as a candidate for weight and lipid disorders. It is not a naturally circulating hormone fragment produced in large amounts.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Derived from C-terminal region of human growth hormone |
| Approximate molecular mass | About 1.8 kDa | Varies with sequence length and counterions |
| Confirmed receptor target | None established | No confirmed growth hormone receptor agonism |
| Reported in vitro activity | Lipolysis stimulation and lipogenesis inhibition | Observed mainly in adipocyte models; human relevance uncertain |
| Regulatory status | Not approved as a drug in major markets | May be treated differently across jurisdictions; not a recognized dietary ingredient in some countries |
Early interest in AOD-9604 centered on whether a fragment of human growth hormone could influence fat metabolism without the broader effects of the full hormone. Cell and animal studies reported changes in fat storage and breakdown. Human trials followed, but the results were not strong enough to secure regulatory approval. The compound remains available for laboratory research, and its clinical potential is still described as uncertain. Studies continue to examine its activity and safety profile.
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
Researchers have studied the fragment in cell and animal models to understand its metabolic actions. Some experiments report effects on fat breakdown and fat storage pathways, but the underlying mechanism remains incompletely defined. AOD-9604 does not appear to stimulate the same broad growth hormone receptor signaling as full-length hGH. Whether its observed activities arise from direct receptor interactions or downstream metabolic changes is an open question. Results from different assays are not always consistent.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to residues 176-191 of the 191-amino-acid hGH sequence. The fragment is not the full hormone and lacks the receptor-binding region associated with growth and metabolic effects of hGH. Researchers developed it to isolate a specific portion of hGH for study. Its exact sequence and length are often stated in peptide catalogs and patents.
The peptide is frequently described as a growth hormone fragment, although it is chemically distinct from full-length hGH. AOD-9604 contains 16 amino acids and includes two cysteine residues that can form an intramolecular disulfide bond. In solution, this structural feature can influence folding, aggregation, and stability. Published descriptions sometimes call it hGH 176-191 or AOD9604, with spacing and capitalization varying. Such naming differences can complicate literature searches, database entries, and product verification.
== Transition Metal-Mediated Bioconjugation Reactions == Transition metal-based bioconjugation had been challenging due to the nature of biological conditions – aqueous solution, room temperature, mild pH, and low substrate concentrations – which are generally challenging for organometallic reactions. However, recently, besides copper-catalyzed [3 + 2] azide alkyne cycloaddition reaction, more and more diverse transition metal-mediated chemical transformations have been applied for bioconjugation reactions, introducing olefin metathesis, alkylation, C–H arylation, C–C, C–S, and C–N cross-coupling reactions.
A continuity equation or transport equation is an equation that describes the transport of some quantity. It is particularly simple and powerful when applied to a conserved quantity, but it can be generalized to apply to any extensive quantity. Since mass, energy, momentum, electric charge and other natural quantities are conserved under their respective appropriate conditions, a variety of physical phenomena may be described using continuity equations. Continuity equations are a stronger, local form of conservation laws. For example, a weak version of the law of conservation of energy states that energy can neither be created nor destroyed—i.e., the total amount of energy in the universe is fixed. This statement does not rule out the possibility that a quantity of energy could disappear from one point while simultaneously appearing at another point. A stronger statement is that energy is locally conserved: energy can neither be created nor destroyed, nor can it "teleport" from one place to another—it can only move by a continuous flow. A continuity equation is the mathematical way to express this kind of statement. For example, the continuity equation for electric charge states that the amount of electric charge in any volume of space can only change by the amount of electric current flowing into or out of that volume through its boundaries.
Essendon Hall of Fame Legends (year inducted): Bill Brew (2013), Bill Busbridge (1996), Jack Clarke (1996), John Coleman (1996), Bill Cookson (1996), Wally Crichton (2010), Terry Daniher (1996), Barry Davis (2006), Ron Evans (2012), Tom Fitzmaurice (1996), Ken Fraser (1996), Allan Hird Sr (1996), James Hird (2011), Harry Hunter (2015), Bill Hutchison (1996), Matthew Lloyd (2013), Simon Madden (1996), Alex McCracken (1996), Michael Long (2010), Howard Okey (2012), Frank Reid (1996), Dick Reynolds (1996), Greg Sewell (2009), Kevin Sheedy (2008), Albert Thurgood (1996), Tim Watson (1998), Neale Daniher* (2018), Dustin Fletcher*, Dr Bruce Reid* (2014), Gavin Wanganeen* *denotes recent elevation to Legend status Essendon Hall of Fame members (year inducted): Noel Allanson (2015), Fred Baring (2013), John Birt (2010), Reg Burgess (2015), Wally Buttsworth (2010), Barry Capuano (2014), Kevin Egan (2015), Alec Epis (2014), Ken Fletcher (2011), Keith Forbes (2010), Garry Foulds (2010), Darryl Gerlach (2013), Mark Harvey (2014), Bruce Heymanson (2013), Jack Jones (2012), Ron Kirwan (2016), Harold Lambert (2018), Scott Lucas (2013), Roy McConnell (2013), Don McKenzie (2010), Roger Merrett (2018), Joe Misiti (2012), Hugh Mitchell (2012), Graham Moss (2012), Gary O'Donnell (2014), Dr Ian Reynolds (2018), Paul Salmon (2012), David Shaw (2011), Arthur Showers (2010), George Stuckey (2010), Hugh Torney (2011), Paul Vander Haar (2015)
Of the people studied, 66% were cocaine users. After experiencing long-term in-patient treatment, only 22% returned to the use of cocaine. During the 1990s, the Clinton administration commissioned a major cocaine policy study by the RAND Drug Policy Research Center. The report recommended that $3 billion be switched from federal and local law enforcement to treatment, concluding that treatment is the cheapest way to cut drug use, and twenty-three times more effective than the supply-side war on drugs.
==== Gamma Spectroscopy ==== Gamma spectroscopy yields results that are conceptually equivalent to alpha-particle spectroscopy, however, can result in sharper peaks due to reduced attenuation of energy. Some radionuclides produce discrete γ-rays that produce energy between a few KeV to 10 MeV which can be measured with a gamma-ray spectrometer. This can be accomplished without destroying the sample. The most common gamma-ray detector is a semiconductor germanium detector which allow for a greater energy resolution than alpha-particle spectroscopy, however gamma spectroscopy only has an efficiency of a few percent. Gamma spectroscopy is a less sensitive method due to low detector efficiency and high background. However, gamma spectroscopy has the advantage of having less time-consuming sample procedures and portable detectors for field use.
Sources: en.wikipedia.org
== History == The U.S. Food and Drug Administration (FDA) approved vericiguat based on evidence from a clinical trial (NCT02861534) which consisted of 5,050 participants aged 23 to 98 years old with worsening heart failure. The trial was conducted at 694 sites in 42 countries in Europe, Asia, North and South America. The trial enrolled participants with symptoms of worsening heart failure. Participants were randomly assigned to receive vericiguat or a placebo pill once a day. Neither the participants nor the health care professionals knew if the participants were given vericiguat or placebo pills until after the trial was complete. It was awarded a fast track designation on 19 January 2021.
Professor of Economics at Princeton University Henrik Kleven has suggested that three distinct policies in Denmark and its Scandinavian neighbours imply that the high tax rates cause only relatively small distortions to the economy:
The nature of the organic group on the silanization agent strongly influences the properties of the surface. Simple alkyl-containing silanizing groups confer hydrophobicity. When side chains of the silane compound are amines or thiols, the surfaces assume the properties of those functional groups. These surfaces are susceptible to further reactions characteristic of the appended functional groups. Grafting can be performed, for example.
Bacteria resist phage infection through restriction modification systems that degrade foreign DNA and a system that uses CRISPR sequences to retain fragments of the genomes of phage that the bacteria have come into contact with in the past, which allows them to block virus replication through a form of RNA interference. Third, bacteria can transfer genetic material through direct cell contact via conjugation. In ordinary circumstances, transduction, conjugation, and transformation involve transfer of DNA between individual bacteria of the same species, but occasionally transfer may occur between individuals of different bacterial species, and this may have significant consequences, such as the transfer of antibiotic resistance. In such cases, gene acquisition from other bacteria or the environment is called horizontal gene transfer and may be common under natural conditions.
Proteins with high net charge will need a higher ionic strength for them to be eluted out of the column. It is possible to perform ion exchange chromatography in bulk, on thin layers of medium such as glass or plastic plates coated with a layer of the desired stationary phase, or in chromatography columns. Thin layer chromatography or column chromatography share similarities in that they both act within the same governing principles; there is constant and frequent exchange of molecules as the mobile phase travels along the stationary phase. It is not imperative to add the sample in minute volumes as the predetermined conditions for the exchange column have been chosen so that there will be strong interaction between the mobile and stationary phases. Furthermore, the mechanism of the elution process will cause a compartmentalization of the differing molecules based on their respective chemical characteristics. This phenomenon is due to an increase in salt concentrations at or near the top of the column, thereby displacing the molecules at that position, while molecules bound lower are released at a later point when the higher salt concentration reaches that area. These principles are the reasons that ion exchange chromatography is an excellent candidate for initial chromatography steps in a complex purification procedure as it can quickly yield small volumes of target molecules regardless of a greater starting volume.
Sources: en.wikipedia.org
A migraine trigger is anything that increases the sensitivity of the brain to migraines. The activity of nerve cells and chemical signals in the brain is affected by genetic, environmental, and neurological factors which interact. Once physical and chemical stimuli exceed an individual's sensitivity threshold, further neurological changes can lead to increased activity in the pain pathway of the brain, with heightened blood flow and transmission of pain signals. Categories of potential migraine triggers include emotions, nutrition, sleep, hormones, weather, environmental factors (noise, smells, lights), and strenuous movement. Internal migraine triggers such as hormones, stress, disturbed sleep, and fasting affect the body's ability to maintain a stable state. External migraine triggers such as temperature, noises, and odors can change how the body reacts to sensory information. Air pollution, in particular nitrous oxide, carbon monoxide, and particulate matter, appears to increase migraine risk. Determining when something truly acts as a causal trigger, as opposed to being a symptom of already occurring changes in the brain, is an ongoing area of research. In some cases, factors reported as triggers, such as sensory sensitivities, food cravings, and mood changes, may instead be symptoms in the early (prodromal) phase of migraine. Relationships between triggers are complex and may be bidirectional.
Perforin's role in protecting the body against lymphoma was emphasized when scientists discovered that p53 did not have as big of a role in lymphoma surveillance as its counterpart perforin. Perforin and granzymes have been found to have a directly related ability to protect the body against the formation of different kinds of lymphomas.
Sterilization is an important factor to consider during the fermentation of foods. Failing to completely remove any microbes from equipment and storing vessels may result in the multiplication of harmful organisms within the ferment, potentially increasing the risks of food borne illnesses such as botulism. However, botulism in vegetable ferments is only possible when not properly canned. The production of off smells and discoloration may be indications that harmful bacteria may have been introduced to the food. Alaska has witnessed a steady increase of cases of botulism since 1985. It has more cases of botulism than any other state in the United States of America. This is caused by the traditional Alaska Native practice of allowing animal products such as whole fish, fish heads, walrus, sea lion, and whale flippers, beaver tails, seal oil, and birds, to ferment for an extended period of time before being consumed. The risk is exacerbated when a plastic container is used for this purpose instead of the old-fashioned, traditional method, a grass-lined hole, as the Clostridium botulinum bacteria thrive in the anaerobic conditions created by the air-tight enclosure in plastic. Research has found that fermented food contains a carcinogenic by-product, ethyl carbamate (urethane). "A 2009 review of the existing studies conducted across Asia concluded that regularly eating pickled vegetables roughly doubles a person's risk for esophageal squamous cell carcinoma."
== Prediction of SUMO attachment == Most SUMO-modified proteins contain the tetrapeptide consensus motif Ψ-K-x-D/E where Ψ is a hydrophobic residue, K is the lysine conjugated to SUMO, x is any amino acid (aa), D or E is an acidic residue. Substrate specificity appears to be derived directly from Ubc9 and the respective substrate motif. Currently available prediction programs are:
analytical: to identify the size of each fraction of a mixture is attributable to each component without attempting to harvest the fractions. preparative: to "prepare" fractions for input into processes that benefit when components are separated. Separations may be performed on a small scale, as in a laboratory for analytical purposes, or on a large scale, as in a chemical plant.
Sources: en.wikipedia.org
AOD9604 is a synthetic peptide based on a C-terminal segment of human growth hormone. It is manufactured by chemical peptide synthesis rather than extracted from human tissue. The sequence is often described as hGH fragment 176–191 or a close variant.
It is not approved as a prescription drug in the United States or the European Union for any indication. Regulatory status can differ by country, and it is often sold as a research chemical or in unapproved products. Such products are not equivalent to an approved medicine.
In the studies reported so far, AOD9604 does not appear to act through the growth hormone receptor and has not shown the typical IGF-1 increase caused by full-length hGH. Human data are limited, so this remains an area of uncertainty. It should not be assumed to have the same effects as hGH.
No major regulatory agency has approved AOD-9604 as a medicine. It is treated as an experimental peptide in research settings. Some countries restrict its sale or import.